The complexity of antibody-dependent enhancement of dengue virus infection - Wikidata - awgldk - TriplyDB

The complexity of antibody-dependent enhancement of dengue virus infection

The complexity of antibody-dependent enhancement of dengue virus infection

http://www.wikidata.org/entity/Q28250383

about

NS1 antigen detecting assays for diagnosing acute dengue infection in people living in or returning from endemic countries Flaviviruses in Europe: complex circulation patterns and their consequences for the diagnosis and control of West Nile disease Rapid evolutionary dynamics of structural disorder as a potential driving force for biological divergence in flaviviruses MEPPitope: spatial, electrostatic and secondary structure perturbations in the post-fusion Dengue virus envelope protein highlights known epitopes and conserved residues in the Zika virus Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates Dengue, Zika and Chikungunya: Emerging Arboviruses in the New World The role of genetics and antibodies in sepsis Epidemiological Characteristics and Risk Factors of Dengue Infection in Korean Travelers High content screening of a kinase-focused library reveals compounds broadly-active against dengue viruses Global climate change and its potential impact on disease transmission by salinity-tolerant mosquito vectors in coastal zones Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice.Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells.Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus Down-regulation of complement receptors on the surface of host monocyte even as in vitro complement pathway blocking interferes in dengue infection.Elevated dengue virus nonstructural protein 1 serum levels and altered toll-like receptor 4 expression, nitric oxide, and tumor necrosis factor alpha production in dengue hemorrhagic Fever patients.Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement.Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes.Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.Mathematical modelling and a systems science approach to describe the role of cytokines in the evolution of severe dengue Forty Years of Dengue Surveillance at a Tertiary Pediatric Hospital in Bangkok, Thailand, 1973-2012.DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.The function of Fcγ receptors in dendritic cells and macrophages.Salidroside exhibits anti-dengue virus activity by upregulating host innate immune factors.Genetic signatures coupled with lineage shift characterise endemic evolution of Dengue virus serotype 2 during 2015 outbreak in Delhi, India.An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.Epidemiological consequences of immune sensitisation by pre-exposure to vector saliva.Generation and characterization of cross neutralizing human monoclonal antibody against 4 serotypes of dengue virus without enhancing activity.Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common m Arthropod EVs mediate dengue virus transmission through interaction with a tetraspanin domain containing glycoprotein Tsp29Fb Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM)

P2860

Q24194181-A3529548-C910-427B-9FA0-A7A4D138FF80 Q24273313-C51CEDC0-B1E4-4F2B-A88E-E0535FA9829B Q24289194-CBB410E5-7055-4969-B244-D619BDF5247C Q26700001-6E04740A-8A33-4AA5-99DA-0A6E390B2EE1 Q26700094-E9CAB483-9966-4FF4-8011-6D78534182C3 Q26700096-8CCD9D78-601A-4F3E-AA2D-422BA10404F3 Q27303669-6AEDAF43-5D02-4FB8-A438-EA72F567BFFC Q28073453-708E940B-FE76-4B7B-B4CD-F505C79B1241 Q28075279-F11961C5-929E-41E7-9B1B-CDF069ADA9E8 Q28080305-80DBF1EC-F2FB-40CC-8882-CEA4C141DD33 Q28486302-0EB6B494-9D4F-455E-AA56-5F361DEF6B77 Q28656304-7607E165-5C6E-4FBB-AA10-FA09D9325020 Q33414560-FFCB7463-15E6-48A1-9AF6-8D0C29FC4F38 Q33681310-69CC33AC-5CBE-40AF-A926-AEFF42CB51C9 Q33850577-63A1D9E3-ACED-48D7-A643-1448AC3C61C1 Q33951623-88341D2C-D88F-4858-90A1-2E1273D1A6F5 Q34785824-3707F9C0-DABE-4AEC-ACF1-500DFB344E61 Q34999863-8E1A55C3-EC63-479D-B277-B16BDA8A4FF8 Q35146621-F85CA37E-2C0D-4874-A357-F4CBF410AADA Q35641205-74803BC5-43B1-44EC-B06C-3F73DFC734F4 Q36305184-7EDB8179-189A-421B-9019-C65F7D368182 Q36958540-31C8E115-8B2B-4EBD-80D6-E2A53ED3C872 Q38157397-12BC7B94-B2F0-4B3F-BA85-49A22DBA9965 Q38180345-EC0786EB-1658-4950-85E0-3BAE1D8DCDAC Q38748779-6CF41FAE-99B8-459A-94FA-AA6283C88D40 Q38764126-4BEFDBDD-E5AE-4518-94BF-AED45F0C5975 Q41928846-7126A304-2819-471C-BA7A-052BB06B23D8 Q44168829-52A063E9-D9B6-47D6-BA39-E010BE8EC13A Q45324646-EE0D6A59-569B-4D63-8BF5-714AAC67C2DB Q51733798-85E0AFDC-BC70-4BC5-A147-6CEA0FD4FD4B Q56342103-49AEB9A9-22ED-4325-8582-3BE1E66BB5DF Q56479686-FC640BBE-50F7-4833-B3A7-006077D8BFA4

P2860

The complexity of antibody-dependent enhancement of dengue virus infection

http://www.wikidata.org/entity/Q28250383

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The complexity of antibody-dependent enhancement of dengue virus infection

@ast

The complexity of antibody-dependent enhancement of dengue virus infection

@en

The complexity of antibody-dependent enhancement of dengue virus infection

@nl

type

label

The complexity of antibody-dependent enhancement of dengue virus infection

@ast

The complexity of antibody-dependent enhancement of dengue virus infection

@en

The complexity of antibody-dependent enhancement of dengue virus infection

@nl

prefLabel

The complexity of antibody-dependent enhancement of dengue virus infection

@ast

The complexity of antibody-dependent enhancement of dengue virus infection

@en

The complexity of antibody-dependent enhancement of dengue virus infection

@nl

P1433

Q28250383-DE153E1E-EB2C-49A8-AD2C-B7FAF1A16B1D

P1476

Q28250383-679D9562-13C2-4712-94FE-DE5663E4B004

P2093

Q28250383-6BEC376B-D1F9-4D8D-8EC4-0CAE3B593E25

Q28250383-75684706-636A-477D-B074-665F1131CC8A

P2860

Q28250383-02A17B7C-2428-4D84-B35F-827FD9BCF2C9

Q28250383-0443D39E-DB38-4D9E-8E9B-0B33BFB9D232

Q28250383-0923366F-40CF-4424-AF1B-218AD38FAA45

Q28250383-0C9E58C5-1634-44F4-A9B6-7FE1D4FEFF5A

Q28250383-12F4880F-A196-45B2-8F3A-79CD45854350

Q28250383-13D8B119-E740-445D-8CE9-9B7295A3E8D3

Q28250383-13F70FDC-6C39-497E-9C5A-E2444259DE6C

Q28250383-17774868-399C-47FB-99C8-8D3DBA9CA579

Q28250383-1B79601A-EC68-4969-B79B-A6921895D493

Q28250383-202F278B-3944-4F24-A00E-03AEC179BDB4

P304

Q28250383-EE217281-9EB2-434F-BF9B-0A8CEDAD2197

P31

Q28250383-1EAB0AC8-C20F-4A0F-8666-6090DD447DA8

P3181

Q28250383-654BCFA9-2BEE-4BEA-8651-43B5E33C0FFB

P356

Q28250383-7BB02DCF-14C1-4EA5-A853-7267D09D2ABC

P407

Q28250383-7DD6DFC5-A854-4D6C-A5C2-F5517A2A5C61

P433

Q28250383-60A19622-9EED-40E2-BF08-DC7926F3F144

P478

Q28250383-E0E29D4F-832A-4704-AF23-F0DAC5D2AB24

P577

Q28250383-E6DC04C0-918D-44F4-8DA8-C384AF49F364

P5875

Q28250383-1B6E0845-4F4F-43A6-A7C9-828F85797B9C

P698

Q28250383-64E62B2B-8343-494B-9AA3-1EC8471C3B95

P921

Q28250383-3077387C-36DF-4329-94EE-73599DBE3E8F

Q28250383-B8C0F348-035E-4F2B-98F8-5A07051F8006

P932

Q28250383-C07B9AAC-00C7-417E-A921-779A7CA8E273

P3181

P356

P1433

P1476

The complexity of antibody-dependent enhancement of dengue virus infection

@en

P2093

Maria G Guzman

http://www.w3.org/2001/XMLSchema#string

Susana Vazquez

http://www.w3.org/2001/XMLSchema#string

P2860

Neutralizing antibodies after infection with dengue 1 virus

Role of dendritic cells in antibody-dependent enhancement of dengue virus infection

Furin at the cutting edge: from protein traffic to embryogenesis and disease

Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention

Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered

Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection.

P304

2649-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1337742

http://www.w3.org/2001/XMLSchema#string

P356

10.3390/V2122649

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51711966

http://www.w3.org/2001/XMLSchema#string

P698

21994635

http://www.w3.org/2001/XMLSchema#string

P921

P932

3185591

http://www.w3.org/2001/XMLSchema#string